These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28796925)

  • 1. Neurological comorbidity in children with neurofibromatosis type 1.
    Hirabaru K; Matsuo M
    Pediatr Int; 2018 Jan; 60(1):70-75. PubMed ID: 28796925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autism and attention-deficit/hyperactivity disorders and symptoms in children with neurofibromatosis type 1.
    Morotti H; Mastel S; Keller K; Barnard RA; Hall T; O'Roak BJ; Fombonne E
    Dev Med Child Neurol; 2021 Feb; 63(2):226-232. PubMed ID: 32406525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autism and other psychiatric comorbidity in neurofibromatosis type 1: evidence from a population-based study.
    Garg S; Lehtonen A; Huson SM; Emsley R; Trump D; Evans DG; Green J
    Dev Med Child Neurol; 2013 Feb; 55(2):139-145. PubMed ID: 23163236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics of boys with comorbid autism spectrum disorder and attention deficit/hyperactivity disorder.
    Yamawaki K; Ishitsuka K; Suyama S; Suzumura S; Yamashita H; Kanba S
    Pediatr Int; 2020 Feb; 62(2):151-157. PubMed ID: 31845457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inattention and hyperactivity/impulsivity among children with attention-deficit/hyperactivity-disorder, autism spectrum disorder, and intellectual disability.
    McClain MB; Hasty Mills AM; Murphy LE
    Res Dev Disabil; 2017 Nov; 70():175-184. PubMed ID: 28957735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of two hundred children with Autism Spectrum Disorder from a tertiary child and adolescent psychiatry centre.
    Kommu JVS; K R G; Srinath S; Girimaji SC; P Seshadri S; Gopalakrishna G; Doddaballapura K S
    Asian J Psychiatr; 2017 Aug; 28():51-56. PubMed ID: 28784397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychiatric disorders in individuals with neurofibromatosis 1 in Denmark: A nationwide register-based cohort study.
    Kenborg L; Andersen EW; Duun-Henriksen AK; Jepsen JRM; Doser K; Dalton SO; Bidstrup PE; Krøyer A; Frederiksen LE; Johansen C; Østergaard JR; Hove H; Sørensen SA; Riccardi VM; Mulvihill JJ; Winther JF
    Am J Med Genet A; 2021 Dec; 185(12):3706-3716. PubMed ID: 34327813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of comorbid ADHD in ASD interventions and outcome: Results from a naturalistic follow up study from south India.
    Manohar H; Kuppili PP; Kandasamy P; Chandrasekaran V; Rajkumar RP
    Asian J Psychiatr; 2018 Mar; 33():68-73. PubMed ID: 29544110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacotherapy for the treatment of aggression in pediatric and adolescent patients with autism spectrum disorder comorbid with attention-deficit hyperactivity disorder: A questionnaire survey of 571 psychiatrists.
    Yamamuro K; Tsujii N; Ota T; Kishimoto T; Iida J
    Psychiatry Clin Neurosci; 2017 Aug; 71(8):554-561. PubMed ID: 28317224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatology of autism spectrum disorder in a population with neurofibromatosis type 1.
    Walsh KS; Vélez JI; Kardel PG; Imas DM; Muenke M; Packer RJ; Castellanos FX; Acosta MT
    Dev Med Child Neurol; 2013 Feb; 55(2):131-138. PubMed ID: 23163951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TAND checklist: a useful screening tool in children with tuberous sclerosis and neurofibromatosis type 1.
    Cervi F; Saletti V; Turner K; Peron A; Bulgheroni S; Taddei M; La Briola F; Canevini MP; Vignoli A
    Orphanet J Rare Dis; 2020 Sep; 15(1):237. PubMed ID: 32894194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency of risk factors and coexisting abnormalities in a population of Egyptian children with autism spectrum disorder.
    Meguid NA; Nashaat NH; Hashem HS; Khalil MM
    Asian J Psychiatr; 2018 Feb; 32():54-58. PubMed ID: 29216607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of bullying and perceived happiness in adolescents with learning disability, intellectual disability, ADHD, and autism spectrum disorder: In the Taiwan Birth Cohort Pilot Study.
    Lung FW; Shu BC; Chiang TL; Lin SJ
    Medicine (Baltimore); 2019 Feb; 98(6):e14483. PubMed ID: 30732217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of the month of birth on the demand for healthcare to treat attention deficit hyperactivity disorder. Results of a retrospective study conducted in a neuropaediatric clinic].
    Rivas-Juesas C; González de Dios J; Benac-Prefaci M; Fernández-Martínez S; Colomer-Revuelta J
    Rev Neurol; 2015 Oct; 61(7):289-94. PubMed ID: 26411272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of Attention-Deficit/Hyperactivity Disorder with Medication in Children with Autism Spectrum Disorder With and Without Intellectual Disability: A DBPNet Study.
    Grater JE; Muniz EI; Silver EJ; Blum NJ; Shults J; Stein REK
    J Autism Dev Disord; 2023 Aug; 53(8):3144-3150. PubMed ID: 35633446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Neurofibromatosis type 1 and attention-deficit disorder. Our current experience].
    Sanchez-Marco SB; Lopez-Pison J; Serrano-Vinuales I; Troyas-Fernandez de Garayalde L; Lafuente-Hidalgo M; Monge-Galindo L
    Rev Neurol; 2019 Jan; 68(1):7-10. PubMed ID: 30560983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding autism spectrum disorder and social functioning in children with neurofibromatosis type 1: protocol for a cross-sectional multimodal study.
    Haebich KM; Pride NA; Walsh KS; Chisholm A; Rouel M; Maier A; Anderson V; Barton B; Silk T; Korgaonkar M; Seal M; Lami F; Lorenzo J; Williams K; Dabscheck G; Rae CD; Kean M; North KN; Payne JM
    BMJ Open; 2019 Sep; 9(9):e030601. PubMed ID: 31558455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Social skills of children with neurofibromatosis type 1.
    Barton B; North K
    Dev Med Child Neurol; 2004 Aug; 46(8):553-63. PubMed ID: 15287247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practitioner's review: medication for children and adolescents with autism spectrum disorder (ASD) and comorbid conditions.
    Popow C; Ohmann S; Plener P
    Neuropsychiatr; 2021 Sep; 35(3):113-134. PubMed ID: 34160787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.